ChREBP: A Glucose-activated Transcription Factor Involved in the Development of Metabolic Syndrome
Year: 2008
Type: review
Abstract: Excess carbohydrate intake leads to fat accumulation and insulin resistance. Glucose and insulin coordinately regulate de novo lipogenesis from glucose in the liver, and insulin activates several transcription factors including SREBP1c and LXR, while those activated by glucose remain unknown. Recently, a carbohydrate response element binding protein (ChREBP), which binds to the carbohydrate response element (ChoRE) in the promoter of rat liver type pyruvate kinase (LPK), has been identified. The target genes of ChREBP are involved in glycolysis, lipogenesis, and gluconeogenesis. Although the regulation of ChREBP remains unknown in detail, the transactivity of ChREBP is partly regulated by a phosphorylation/dephosphorylation mechanism. During fasting, protein kinase A and AMP-activated protein kinase phosphorylate ChREBP and inactivate its transactivity. During feeding, xylulose-5-phosphate in the hexose monophosphate pathway activates protein phosphatase 2A, which dephosphorylates ChREBP and activates its transactivity. ChREBP controls 50% of hepatic lipogenesis by regulating glycolytic and lipogenic gene expression. In ChREBP (-/-) mice, liver triglyceride content is decreased and liver glycogen content is increased compared to wild-type mice. These results indicate that ChREBP can regulate metabolic gene expression to convert excess carbohydrate into triglyceride rather than glycogen. Furthermore, complete inhibition of ChREBP in ob/ob mice reduces the effects of the metabolic syndrome such as obesity, fatty liver, and glucose intolerance. Thus, further clarification of the physiological role of ChREBP may be useful in developing treatments for the metabolic syndrome.
Source: Endocrine Journal
Authors: Katsumi IIZUKA, Yukio HORIKAWA
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: ChREBP, metabolic syndrome, hepatic lipogenesis, glucose metabolism, insulin resistance, protein phosphorylation, hexose monophosphate pathway, xylulose-5-phosphate, protein phosphatase 2A, protein kinase A, AMPK, hepatic triglycerides, liver glycogen, obesity, hepatic steatosis, impaired glucose tolerance
Open Access status: bronze
OpenAlex ID: W1983144305
